Alectinib in Neo-adjuvant Treatment of Stage III NSCLC
Alectinib in Neo-adjuvant Treatment of Stage III NSCLC
Active, not recruiting · NCT05015010 · Registry updated 2024-08-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Alectinib in Neo-adjuvant Treatment of Stage III NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2024-08-09 | NCT05015010 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gruppo Oncologico Italiano di Ricerca Clinica | 14 |
20 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.